DK2316530T3 - Triglycerider, fedtsyrer, alkoholer som cns-modulatorer - Google Patents

Triglycerider, fedtsyrer, alkoholer som cns-modulatorer

Info

Publication number
DK2316530T3
DK2316530T3 DK10184846.3T DK10184846T DK2316530T3 DK 2316530 T3 DK2316530 T3 DK 2316530T3 DK 10184846 T DK10184846 T DK 10184846T DK 2316530 T3 DK2316530 T3 DK 2316530T3
Authority
DK
Denmark
Prior art keywords
triglycerides
alcohols
fat acids
cns modulators
cns
Prior art date
Application number
DK10184846.3T
Other languages
English (en)
Inventor
Wilfred Dimpfel
David Greenwood
Original Assignee
Btg Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Btg Int Ltd filed Critical Btg Int Ltd
Application granted granted Critical
Publication of DK2316530T3 publication Critical patent/DK2316530T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK10184846.3T 2004-05-12 2005-05-12 Triglycerider, fedtsyrer, alkoholer som cns-modulatorer DK2316530T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57013704P 2004-05-12 2004-05-12
GB0420856A GB0420856D0 (en) 2004-09-20 2004-09-20 Cns modulators
EP05742109.1A EP1755743B1 (en) 2004-05-12 2005-05-12 Beta hydroxybutyrate and derivatives for treating depression and anxiety

Publications (1)

Publication Number Publication Date
DK2316530T3 true DK2316530T3 (da) 2014-11-03

Family

ID=33306877

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10184846.3T DK2316530T3 (da) 2004-05-12 2005-05-12 Triglycerider, fedtsyrer, alkoholer som cns-modulatorer
DK05742109.1T DK1755743T3 (da) 2004-05-12 2005-05-12 Beta-hydroxybutyrat og derivater til behandling af depression og angst

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK05742109.1T DK1755743T3 (da) 2004-05-12 2005-05-12 Beta-hydroxybutyrat og derivater til behandling af depression og angst

Country Status (8)

Country Link
US (3) US20080058416A1 (da)
EP (2) EP2316530B1 (da)
DK (2) DK2316530T3 (da)
ES (2) ES2410588T3 (da)
GB (1) GB0420856D0 (da)
PL (2) PL1755743T3 (da)
PT (1) PT1755743E (da)
WO (1) WO2005107875A2 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0427145D0 (en) * 2004-12-10 2005-01-12 Ketocytonyx Inc Compositions for use in surgery
RU2459624C2 (ru) 2007-04-12 2012-08-27 Риджентс Оф Дзе Юниверсити Оф Миннесота Защитные композиции от ишемии/реперфузии и способы применения
BR112015024186B1 (pt) 2013-03-19 2023-05-09 University Of South Florida Composições e métodos para produção de cetose de elevação e manutenção
US10568854B2 (en) 2014-05-30 2020-02-25 The Johns Hopkins University Compositions and methods for treating kabuki syndrome and related disorders
US10980764B1 (en) 2016-02-01 2021-04-20 University Of South Florida Exogenous ketone supplements for reducing anxiety-related behavior
US10973786B2 (en) 2016-03-11 2021-04-13 Axcess Global Sciences, Llc R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions
US10736861B2 (en) 2016-03-11 2020-08-11 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US11185518B2 (en) 2017-12-19 2021-11-30 Axcess Global Sciences, Llc S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer
US10973792B2 (en) 2019-02-13 2021-04-13 Axcess Global Sciences, Llc Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11026929B2 (en) 2016-04-19 2021-06-08 Keto Patent Group, Inc. Administration of berberine metabolites
CA3021784A1 (en) * 2016-04-19 2017-10-26 Keto Patent Group, Inc. Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
WO2018009208A1 (en) * 2016-07-08 2018-01-11 Cognate Nutritionals, Inc. Nutritional mitiggation of the cns effects of traumatic brain injury
US20180057846A1 (en) 2016-08-30 2018-03-01 KetoneAid Inc. Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy
US10307398B2 (en) 2016-09-20 2019-06-04 Regents Of The University Of Minnesota Resuscitation composition and methods of making and using
US10945975B2 (en) 2016-10-24 2021-03-16 University Of South Florida Delaying latency to seizure by combinations of ketone supplements
US20180177753A1 (en) * 2016-12-23 2018-06-28 Neuroenergy Ventures, Inc. Glyceryl 3-hydroxybutyrates for migraine symptom management
US9925164B1 (en) 2017-01-12 2018-03-27 Neuroenergy Ventures, Inc. Glyceryl 3-hydroxybutyrates for traumatic brain injury
US10376528B2 (en) 2017-03-10 2019-08-13 Tecton Group, Llc Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor
US11760963B2 (en) 2017-08-23 2023-09-19 KetoneAid Inc. Ketogenic beer and alcoholic beverage mixture containing non-racemic ethyl 3-hydroxybutyrate and/or 1,3 butanediol
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US11129802B2 (en) 2018-08-27 2021-09-28 Axcess Global Sciences, Llc Compositions and methods for delivering cannabidiol and ketone bodies
US20200061023A1 (en) * 2018-08-27 2020-02-27 Axcess Global Sciences, Llc Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
US11241401B2 (en) 2020-02-06 2022-02-08 Axcess Global Sciences, Llc Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions
US11419836B2 (en) 2019-02-13 2022-08-23 Axcess Global Sciences, Llc Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US10980772B2 (en) 2018-08-27 2021-04-20 Axcess Global Sciences, Llc Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
MX2021014546A (es) 2019-05-30 2022-01-06 Neuroenergy Ventures Inc Tris (beta-hidroxibutirato) de glicerilo y ataques isquemicos transitorios neuronales.
US11033553B2 (en) 2019-06-21 2021-06-15 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
TWI804037B (zh) * 2021-11-02 2023-06-01 長庚醫療財團法人高雄長庚紀念醫院 生酮飲食之評估系統及其運作方法
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637726A (da) * 1962-09-26
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
DE2733202A1 (de) * 1976-08-04 1978-02-09 Agroferm Ag Verfahren zur herstellung der d(-)-3-hydroxybuttersaeure
US4067999A (en) * 1976-12-15 1978-01-10 Food Technology Products Control of hemorrhagic enteritis in turkeys
US4234599A (en) * 1978-10-04 1980-11-18 Scott Eugene J Van Treatment of skin keratoses with α-hydroxy acids and related compounds
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
US4351835A (en) * 1981-04-01 1982-09-28 Montefiore Hospital Method for preventing body fat deposition in mammals
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
DE3229955A1 (de) * 1982-08-12 1984-02-16 Erichsen, Friedrich Karl, Dr., 2351 Schillsdorf Arzneimittel mit analgetischer wirkung
US4701443A (en) * 1983-03-22 1987-10-20 Baxter Travenol Laboratories, Inc. Nutrient polyesters
US5100677A (en) * 1985-12-18 1992-03-31 Veech Richard L Fluid therapy with various organic anions
DE3581407D1 (de) * 1985-09-06 1991-02-21 Nestle Sa Bewahrung lebender gewebe.
GB8525666D0 (en) * 1985-10-17 1985-11-20 Ici Plc Chemical process
US5719119A (en) * 1985-12-18 1998-02-17 British Technology Group, Ltd. Parenteral nutrition therapy with amino acids
WO1987003809A1 (en) * 1985-12-20 1987-07-02 Veech Richard L Preparation of electrolyte solutions and containers
US5126373A (en) * 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
US4997976A (en) * 1988-11-15 1991-03-05 Henri Brunengraber Use of 1,3-butanediol acetoacetate in parenteral oral nutrition
US5292774A (en) * 1988-07-26 1994-03-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts
US5116868A (en) * 1989-05-03 1992-05-26 The Johns Hopkins University Effective ophthalmic irrigation solution
EP0522422A3 (en) * 1991-07-01 1993-03-17 Mitsubishi Kasei Corporation Process for producing a biodegradable polymer
US5654266A (en) * 1992-02-10 1997-08-05 Chen; Chung-Ho Composition for tissues to sustain viability and biological functions in surgery and storage
US5348979A (en) * 1992-12-23 1994-09-20 Iowa State University Research Foundation Inc. Method of promoting nitrogen retention in humans
WO1995009144A1 (en) * 1993-09-30 1995-04-06 Eastman Chemical Company Nutritive water soluble glycerol esters of hydroxy butyric acid
US5912269A (en) * 1996-04-30 1999-06-15 Vertex Pharmaceuticals, Inc. Butyrate prodrugs derived from lactic acid
JP4598203B2 (ja) * 1995-12-01 2010-12-15 ビーティージー・インターナショナル・リミテッド 脳機能改善剤
JPH10158166A (ja) * 1996-12-02 1998-06-16 Taisho Pharmaceut Co Ltd 貼付剤
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
DK1017379T3 (da) * 1997-03-17 2015-02-16 Btg Int Ltd Terapeutiske sammensætninger omfattende ketonforbindelser og forstadier deraf
US6207217B1 (en) * 1998-01-07 2001-03-27 Pioneer Hi-Bred International, Inc. Animal nutrition compositions
EP0948963B1 (en) * 1998-01-21 2003-05-07 Fideline Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
US6380244B2 (en) * 1998-07-22 2002-04-30 Metabolix, Inc. Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers
DK1123094T3 (da) * 1998-09-15 2007-08-20 Btg Int Ltd Terapeutiske præparater (II)
US6835750B1 (en) * 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
WO2001082928A1 (en) * 2000-05-01 2001-11-08 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism
WO2002062327A2 (en) * 2001-02-07 2002-08-15 Likhodi Serguei S Method of treating neurological disorders using acetone derivatives
US20020132846A1 (en) * 2001-02-26 2002-09-19 Caleb Stone Use of gamma substituted gamma-butyrolactones to increase levels of their corresponding substituted gamma-hydroxybutyrate derivatives in humans
WO2002102363A1 (en) * 2001-06-20 2002-12-27 Lorus Therapeutics Inc. Biological response modifier composition and uses thereof
US6579543B1 (en) * 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin
JP2003306430A (ja) * 2002-04-16 2003-10-28 Lion Corp 皮膚外用剤組成物
ES2670413T3 (es) * 2003-06-03 2018-05-30 The United States Government As Represented By The Department Of Health And Human Services Suplementos nutricionales y composiciones terapéuticas que comprenden derivados de (R)-3-hidroxibutirato
US20050113449A1 (en) * 2003-10-08 2005-05-26 Renshaw Perry F. Enhanced efficacy of omega-3 fatty acid therapy in the treatment of psychiatric disorders and other indications
CA2542023A1 (en) * 2003-10-08 2005-09-22 The Mclean Hospital Corporation Methods of treating psychiatric, substance abuse, and other disorders using combinations containing omega-3 fatty acids

Also Published As

Publication number Publication date
US20220202760A1 (en) 2022-06-30
WO2005107875A2 (en) 2005-11-17
DK1755743T3 (da) 2013-06-10
WO2005107875A3 (en) 2006-03-23
GB0420856D0 (en) 2004-10-20
ES2410588T3 (es) 2013-07-02
PT1755743E (pt) 2013-06-03
US20080058416A1 (en) 2008-03-06
PL1755743T3 (pl) 2013-08-30
EP1755743B1 (en) 2013-04-24
EP2316530B1 (en) 2014-08-13
ES2513890T3 (es) 2014-10-27
EP1755743A2 (en) 2007-02-28
US20140296337A1 (en) 2014-10-02
PL2316530T3 (pl) 2015-01-30
EP2316530A1 (en) 2011-05-04

Similar Documents

Publication Publication Date Title
DK2316530T3 (da) Triglycerider, fedtsyrer, alkoholer som cns-modulatorer
DE602006017397D1 (de) Leistungsteiler
ES2356376T8 (es) Procedimiento cosmetico para las axilas.
DK1735286T3 (da) Tetrahydroindazoler som cannabinoidmodulatorer
DE602005001349D1 (de) Hebelsteckverbinder
DK1902037T3 (da) 2,4-diamino-pyrimidiner som auroainhibitorer
BRPI0512560A (pt) biodiesels ramificados
FR2882056B1 (fr) Dipyrromethenes-bore borocarbones insatures
DK2447252T3 (da) Theramuteinmodulatorer
DE602005003280D1 (de) Hebelsteckverbinder
FIU20050396U0 (fi) Kuoripuristin
DE602006001668D1 (de) Fehlerüberprüfungsverfahren
DE602006006692D1 (de) Konzentrierte flüssige triazolfungizidformulierungen
ITVA20050017A1 (it) Superficie interattiva
DOS2005000061S (es) Confiteria
FI20040387A0 (fi) Paineastia
FR2882055B1 (fr) Dibenzopyrromethenes-bore borocarbones insatures
DK1804780T3 (da) Fedtalkohol med middel kædelængde som hæmatopoiesestimulatorer
ES1059621Y (es) Caramelo.
ES1056532Y (es) Astil para productos de confiteria.
SE0402526D0 (sv) Lipids
FI20051209A (fi) Yläpuolelta pinnan alle painattava vaappu
UA11607S (uk) Цукерка
UA10334S (uk) Цукерка
UA10968S (uk) Цукерка